Anti‐apoptotic activity of low levels of wild‐type p53.
暂无分享,去创建一个
[1] David E. Housman,et al. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours , 1996, Nature.
[2] Lawrence A. Donehower,et al. Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53 , 1995, Nature.
[3] Guillermina Lozano,et al. Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53 , 1995, Nature.
[4] M. Oren,et al. p53-independent death and p53-induced protection against apoptosis in fibroblasts treated with chemotherapeutic drugs. , 1995, British Journal of Cancer.
[5] T. Jacks,et al. A subset of p53-deficient embryos exhibit exencephaly , 1995, Nature Genetics.
[6] P. Romeo,et al. Loss of TAL‐1 protein activity induces premature apoptosis of Jurkat leukemic T cells upon medium depletion. , 1995, The EMBO journal.
[7] M. Kastan,et al. Growth factor modulation of p53-mediated growth arrest versus apoptosis. , 1995, Genes & development.
[8] M. Oren,et al. Biochemical properties and biological effects of p53. , 1995, Current opinion in genetics & development.
[9] N. Hay,et al. Myc-mediated apoptosis requires wild-type p53 in a manner independent of cell cycle arrest and the ability of p53 to induce p21waf1/cip1. , 1994, Genes & development.
[10] H. Hermeking,et al. Mediation of c-Myc-induced apoptosis by p53. , 1994, Science.
[11] M. Karin,et al. p53-Dependent apoptosis in the absence of transcriptional activation of p53-target genes , 1994, Nature.
[12] E. May,et al. Induction of apoptosis by transiently transfected metabolically stable wt p53 in transformed cell lines. , 1994, Cell death and differentiation.
[13] G. Evan,et al. c‐Myc‐induced apoptosis in fibroblasts is inhibited by specific cytokines. , 1994, The EMBO journal.
[14] R. Weinberg,et al. Tumor spectrum analysis in p53-mutant mice , 1994, Current Biology.
[15] C. Harris,et al. p53: at the crossroads of molecular carcinogenesis and risk assessment. , 1993, Science.
[16] D. Housman,et al. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents , 1993, Cell.
[17] J. Roth,et al. A retroviral wild-type p53 expression vector penetrates human lung cancer spheroids and inhibits growth by inducing apoptosis. , 1993, Cancer research.
[18] A. Levine,et al. Identification and characterization of multiple mdm-2 proteins and mdm-2-p53 protein complexes. , 1993, Oncogene.
[19] J. Lotem,et al. Hematopoietic cells from mice deficient in wild-type p53 are more resistant to induction of apoptosis by some agents. , 1993, Blood.
[20] A. Levine,et al. The p53-mdm-2 autoregulatory feedback loop. , 1993, Genes & development.
[21] C. Purdie,et al. Thymocyte apoptosis induced by p53-dependent and independent pathways , 1993, Nature.
[22] Scott W. Lowe,et al. p53 is required for radiation-induced apoptosis in mouse thymocytes , 1993, Nature.
[23] N. Hay,et al. Myc-mediated apoptosis is blocked by ectopic expression of Bcl-2 , 1993, Molecular and cellular biology.
[24] S. Ben‐Sasson,et al. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation , 1992, The Journal of cell biology.
[25] G. Evan,et al. Cooperative interaction between c-myc and bcl-2 proto-oncogenes , 1992, Nature.
[26] M. Gossen,et al. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[27] P. Shaw,et al. Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[28] Gerard I. Evan,et al. Induction of apoptosis in fibroblasts by c-myc protein , 1992, Cell.
[29] M. Raff,et al. Social controls on cell survival and cell death , 1992, Nature.
[30] A. Levine,et al. p53 alteration is a common event in the spontaneous immortalization of primary BALB/c murine embryo fibroblasts. , 1991, Genes & development.
[31] P. Schmid,et al. Expression of p53 during mouse embryogenesis. , 1991, Development.
[32] B. Vogelstein,et al. p53 mutations in human cancers. , 1991, Science.
[33] O. Halevy,et al. Conditional inhibition of transformation and of cell proliferation by a temperature-sensitive mutant of p53 , 1990, Cell.
[34] G. Demers,et al. Loss of normal p53 function confers sensitization to Taxol by increasing G2/M arrest and apoptosis , 1996, Nature Medicine.